Quidel has secured the CE Mark for its Savanna molecular analyzer and its Savanna Respiratory Viral Panel-4 (RVP4) Assay, which will allow the firm to market the system in Europe.
Savanna allows users to analyze 12 pathogens in a single test that lasts less than 30 minutes, according to Quidel. Its Savanna RVP4 Assay is a nucleic acid test to detect influenza, respiratory syncytial virus, and SARS-CoV-2, the company said.